Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Non-Current Assets (2018 - 2025)

Viemed Healthcare's Non-Current Assets history spans 8 years, with the latest figure at $150.7 million for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 21.32% year-over-year to $150.7 million; the TTM value through Dec 2025 reached $150.7 million, up 21.32%, while the annual FY2025 figure was $150.7 million, 21.32% up from the prior year.
  • Non-Current Assets reached $150.7 million in Q4 2025 per VMD's latest filing, down from $152.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $152.4 million in Q3 2025 to a low of $64.0 million in Q2 2021.
  • Average Non-Current Assets over 5 years is $101.5 million, with a median of $113.4 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: rose 1.58% in 2021, then skyrocketed 52.84% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $70.7 million in 2021, then grew by 9.41% to $77.3 million in 2022, then surged by 50.75% to $116.5 million in 2023, then rose by 6.57% to $124.2 million in 2024, then increased by 21.32% to $150.7 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Non-Current Assets are $150.7 million (Q4 2025), $152.4 million (Q3 2025), and $129.3 million (Q2 2025).